-
Type 2 Diabetes Mellitus
- Possibly effective in small studies lowering Fasting Blood Sugar and Hemoglobin A1C
-
Liver disease (Cirrhosis, Hepatitis, NAFLD)
- Mixed results in Clinical Trials
- Amanita phalloides Poisoning
- Insufficient evidence to date
- Other Investigational uses
- Cytoprotection (environmental hazards, Chemotherapy)
- Anticarcinogen
- Ragweed Allergy
- Risk of Allergic Reaction
-
Hormone sensitive conditions (e.g. Breast Cancer)
- Milk Thistle may have Estrogenic effects
- Mild gastrointestinal upset or Dyspepsia
- Avoid in pregnancy (unknown safety)
- Avoid in Lactation (unknown safety)
- No significant interactions
- Possible CYP2C9 Inhibitor, CYP3A4 Inhibitor, P-Glycoprotein Inhibitor depending on Genotype
- However does not appear to result in Clinically Significant interactions in humans
- Optimal dosing not yet established
- Study doses vary from 210 to 600 mg daily
- (2023) Presc Lett 30(8): 48
- Rainone (2005) Am Fam Physician 72:1285-8 [PubMed]